Beyond Erα, estrogen-induced GPER activation initiates intracellular signaling pathways and triggers changes in gene expression via heterotrimeric G proteins, thus impacting cancer growth, invasion, and metastasis [141,151,152]. The gene discussed is GPER1; the disease is cancer.